UPDATED Apr 18, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NXSN | ₪47.75 | 14.4% | 285.1% | ₪3.8b | n/a | PE36.1x | n/a | 1.4% | ||
TLSY | ₪211.40 | 0.4% | 2.3% | ₪1.8b | n/a | PE14.4x | n/a | 6.5% | ||
ORTC | ₪14.47 | -0.1% | -27.8% | ₪64.7m | n/a | PS13.8x | n/a | 6.9% | ||
ININ | ₪2.98 | 8.1% | -11.5% | ₪130.6m | n/a | PB1.1x | n/a | 0% | ||
MCRNT | ₪1.80 | 8.0% | -8.7% | ₪16.9m | n/a | PS6.2x | n/a | 0% | ||
ECPA-M | ₪1.52 | 1.2% | 23.8% | ₪149.0m | n/a | PS13x | n/a | n/a | ||
DNA | ₪0.89 | 3.7% | 24.0% | ₪109.4m | n/a | PS357.4x | n/a | n/a | ||
UNIT | ₪36.96 | 9.2% | 104.4% | ₪514.3m | n/a | PE12.5x | n/a | 7.5% | ||
CLAB | ₪16.60 | 0.06% | 5.5% | ₪140.8m | n/a | PE6.9x | n/a | n/a | ||
FGAS | ₪10.21 | -3.1% | 74.9% | ₪214.6m | n/a | PS6.3x | n/a | n/a | ||
STG | ₪41.88 | 2.6% | 39.2% | ₪194.7m | n/a | PE10.6x | n/a | 0% | ||
ICON | ₪4.56 | -2.9% | -21.7% | ₪257.4m | n/a | PE7.9x | n/a | 3.9% | ||
ARD | ₪49.08 | 3.5% | 12.2% | ₪1.2b | n/a | PE11.8x | n/a | 3.6% | ||
ORAD | ₪0.58 | 3.9% | 17.8% | ₪54.3m | n/a | PE8.7x | n/a | n/a | ||
PCBT | ₪3.68 | 1.0% | 72.0% | ₪263.8m | n/a | PB0.9x | n/a | 8.2% | ||
NYAX | ₪94.00 | -2.9% | 49.0% | ₪3.3b | ₪80.93 | PS3.7x | E139.1% | n/a | ||
SNCM | ₪1.03 | 0.9% | -24.7% | ₪224.6m | n/a | PE10.1x | n/a | 53.4% | ||
INTR | ₪59.97 | 0% | -15.2% | ₪121.7m | n/a | PE13.2x | n/a | 0.8% |